Trendlines Group

Funds

Trendlines appointed agrifood tech co-investor by Enterprise Singapore's Seeds Capital

SINGAPORE (Jan 16): Trendlines Group says its new US$40 million Singapore venture fund ($54.2 million) has been appointed as a partner under the Startup SG Equity scheme, which is administered by Enterprise Singapore investment arm Seeds Capital.

Broker's Calls

Trendlines remains undervalued and 'overweight': NRA

SINGAPORE (June 28): NRA Capital is reiterating its “overweight” recommendation on Trendlines Group with a fair value estimate of 22.5 cents.

Trendlines receives FDA regulatory clearance for meniscus repair system

SINGAPORE (June 19): Trendlines Group announced that its portfolio company, Arcuro Medical, has received regulatory clearance from the United States Food and Drug Administration (FDA) for its SuperBall meniscus repair system.

Trendlines' Saturas completes investment round of US$4 mil

SINGAPORE (Feb 26): Trendlines announced that its portfolio company Saturas has completed an investment round of US$4 million ($5.27 million).

Trendlines teams up with Ozi Amanat as Startup SG Equity co-investors

SINGAPORE (Feb 8): Trendlines Medical Singapore, a subsidiary of Israeli company The Trendlines Group, is partnering Singapore-based investor Ozi Amanat’s venture capital firm, K2 Global, to collaborate in SPRING SEEDS Capital’s (SSC) $100 million inv

In print this week

Finally, some good news for long-suffering Trendlines investors

SINGAPORE (Dec 8): The Trendlines Group’s announcement at end-October that it will start paying dividends in the next financial year could boost returns for long-suffering shareholders of the medical technology incubator.

Trendlines Medical makes maiden investment in medical device startup

SINGAPORE (Oct 16): Trendlines Medical Singapore, a 76.43%-owned subsidiary of Catalist-listed Israeli company The Trendlines Group, has made its first investment by committing a total of US$60,000 ($81,150) to a medical device start-up, InterVaal.

Trendlines in private placement to raise $14 mil

SINGAPORE (Oct 10): Trendlines Group, the investor, incubator and developer of early-stage medical and agricultural startup in Israel is raising net proceeds of $13.34 million by placing out 100 million new shares at 14.03 cents each.

Trendlines to sell entire 6% stake in MitrAssist Medical for US$1.15 mil

SINGAPORE (Aug 30): A subsidiary of Trendlines Group is disposing its entire 6% stake in MitrAssist Medical for a consideration of US$1.15 million ($1.55 million).

Trendlines joint fund establishes new company to research crop protection

SINGAPORE (June 27): Trendlines Group, the Catalist-listed innovation commercialisation company based in Israel, has announced that its Bayer Trendlines Ag Innovation Fund will be establishing a new company, ABI-Ag, to conduct specific research in the fie
×